++
For further information, see CMDT Part 26-10: Thyroid Eye Disease
++
A syndrome of clinical and orbital imaging abnormalities caused by deposition of mucopolysaccharides and infiltration with chronic inflammatory cells of the orbital tissues, particularly the extraocular muscles
The early inflammatory stage typically lasts 18–36 months, during which there is active lymphocytic infiltration into retrobulbar tissues
The active inflammatory stage then tends to evolve to a chronic, fibrotic, "burned out" stage in which treatment of the exophthalmos is medically resistant to glucocorticoid treatment
Radioiodine therapy, possibly indirectly due to induction of hypothyroidism, and cigarette smoking increase its severity
Ethanol injection of thyroid nodules has been reported to be followed by severe disease
++
Primary clinical features
Upper eyelid retraction (Dalrymple sign)
Lid lag with downward gaze (von Graefe sign)
Staring appearance (Kocher sign)
The following can also be seen:
Corneal drying may occur with inadequate lid closure
Eye changes may sometimes be asymmetric or unilateral
Resulting symptoms
Patients with severe exophthalmos can experience
Symptoms of active retrobulbar inflammation include
Retrobulbar aching
Orbital inflammation and edema worse after recumbent sleep
Edematous or erythematous eyelids
Conjunctival redness or chemosis (edema)
Recent progression in exophthalmos
Recent diplopia or strabismus
Recent loss of visual acuity
Differential diagnosis
++
Exophthalmometry should be performed on all patients with Graves disease to
The protrusion of the eye beyond the orbital rim is measured with a prism instrument (Hertel exophthalmometer)
Maximum normal eye protrusion varies between kindreds and races
About 24 mm for Black patients
About 20 mm for White patients
About 18 mm for Asian patients
++
General eye protective measures include wearing glasses to protect the protruding eye and taping the lids shut during sleep if corneal drying is a problem
Methylcellulose drops and gels ("artificial tears") may also help
Mild disease: Oral selenium (100 mcg twice daily) may slow progression
The Mourits clinical activity score
Helps grade the severity of thyroid eye disease
Therapy in addition to selenium is warranted for active thyroid eye disease with a clinical activity point score ≥ 3
One point is given for each of the following manifestations:
Pain or pressure in the periorbital area
Pain with eye movement
Swelling of the eyelids
Erythema of the eyelids
Conjunctival injection
Chemosis
Caruncle inflammation
Increase in proptosis of ≥ 2 mm within 3 months
Decrease in eye movement within 3 months
Decrease in visual activity within 3 months
Intravenous pulse methylprednisolone